|
ABOUT COMPANY
Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut.
|
EARNINGS
Gross Profit (TTM): 21801800
Market Capitalization: 4342873000
Operating Margin (TTM): -8.15
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.478
Revenue (TTM): 22586300
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.222
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.798
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -64270736
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|